Using AI to detect heart valve disease with a stethoscope
Detection of Valvular Heart Disease Using Artificial Intelligence-based Stethoscope
This study is testing a new app that uses artificial intelligence to listen to heart sounds and help doctors diagnose heart valve disease earlier in people who have recently had an echocardiogram.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Sun Yat-sen University Academic / other |
| Locations | 1 site (Guangzhou, Guangdong) |
| Trial ID | NCT06386016 on ClinicalTrials.gov |
What this trial studies
This study aims to develop an artificial intelligence-based application that analyzes heart sounds to diagnose valvular heart disease. By utilizing deep learning techniques, the application seeks to enhance the screening process for patients at risk of this condition. The goal is to promote earlier clinical monitoring and intervention, potentially improving patient outcomes. Participants will include individuals who have recently undergone echocardiography for valvular heart disease diagnosis.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 who have recently had echocardiography indicating either a diagnosis or exclusion of valvular heart disease.
Not a fit: Patients who have undergone prosthetic valve replacement, have congenital heart disease (except bilobal aortic valve), or are pregnant or lactating may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to earlier detection and treatment of valvular heart disease, improving patient outcomes.
How similar studies have performed: While the use of AI in medical diagnostics is a growing field, this specific application for valvular heart disease detection is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age\>18 years 2. In the past 1 month, echocardiography was performed to diagnose valvular heart disease (positive group) and echocardiography to exclude valvular heart disease (negative group). 3. Consent to study and be able to sign informed consent Exclusion Criteria: 1. After prosthetic valve replacement 2. Congenital heart disease (except bilobal aortic valve) 3. Hypertrophic Cardiomyopathy（HCM） 4. Pregnant, lactating women
Where this trial is running
Guangzhou, Guangdong
- First Affiliated Hospital, Sun Yat-Sen University — Guangzhou, Guangdong, China (Recruiting)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.